GLP-1 Medications and Heart Rate: Is a Small Increase Normal?
A modest rise in resting heart rate is recognized. Here is what it means and when to report it.
The short answer
GLP-1 medications can cause a small increase in resting heart rate (often a few beats per minute on average). For most people this is modest and not dangerous, and it is separate from the cardiovascular benefits semaglutide showed in the SELECT trial (PMID 37952131). Still, palpitations or a noticeably fast heartbeat are worth reporting.
Why it happens
This mild heart-rate effect is a recognized property of GLP-1 medications. It is usually small and well tolerated. It does not cancel out the heart benefits seen in trials, where semaglutide reduced cardiovascular events in a specific high-risk population, but it is something clinicians keep an eye on.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.
Start the 30-day trialWhat to watch for
Tell your physician if you feel a racing or pounding heartbeat, palpitations, chest discomfort, or shortness of breath, or if you have a known heart-rhythm condition. They can monitor your heart rate and decide whether any change to the plan is needed.
How this relates to what we offer
Our review covers heart history, and follow-up lets us monitor how you respond rather than starting a medication and walking away.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location. In person in Orange County and by telehealth for eligible patients in California.
Frequently asked questions
Do GLP-1 medications raise heart rate?
They can cause a small increase in resting heart rate, often a few beats per minute on average. For most people it is modest and well tolerated, but report palpitations or a noticeably fast heartbeat.
Is the heart-rate increase dangerous?
For most people it is modest and not dangerous. People with heart-rhythm conditions need physician oversight. Report palpitations, chest discomfort, or shortness of breath.
Doesn't semaglutide help the heart?
Yes, in the SELECT trial (PMID 37952131) semaglutide reduced cardiovascular events in a specific high-risk population. The mild resting heart-rate effect is separate and usually minor.
Should I check my pulse on a GLP-1?
If you have a heart condition or feel palpitations, mention it so your physician can monitor. Routine concern is low for most people, but reporting symptoms is wise.
Does New Hope review heart history?
Yes. Our review covers heart history, and follow-up lets us monitor your response rather than starting a medication and walking away.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.